Department of Pharmaceutical Technology, Faculty of Pharmacy, Ege University, 35100 Bornova, Izmir, Turkey.
AAPS PharmSciTech. 2010 Mar;11(1):181-8. doi: 10.1208/s12249-009-9374-3. Epub 2010 Jan 26.
Gel formulations of mebeverine hydrochloride (MbHCl) containing hydroxypropylmethylcellulose (HPMC), metolose (MTL), and poloxamer 407 (PLX) were prepared to be used in the treatment of different oral painful conditions. HPMC was used as a mucoadhesive gel base while MTL and PLX were used to prepare sol-gel thermosensitive gels. MTL and PLX formulations showed proper sol-gel transition temperature for intraoral application. Formulations were evaluated in terms of their viscosity, mechanical properties, mucoadhesivity, stability, and in vitro drug release. The formulation prepared with 2% of HPMC K100M provided the highest viscosity at room temperature. However, the viscosity of HPMC-PLX mixture showed a significant increase at body temperature. The greatest mucoadhesion was also noted in HPMC-PLX combinations. Texture profile analysis exhibited the differences of the adhesion, hardness, elasticity, cohesiveness, and compressibility of the formulations. The release profiles of MbHCl were obtained, and non-Fickian release was observed from all the formulations. The formulations were stored at different temperature and relative humidity. No significant changes were observed at the end of the 3 months. HPMC-PLX formulation of MbHCl was chosen for in vivo studies, and it remained longer than dye solution on the rabbit's intraoral mucosal tissue. It was found worthy of further clinical evaluation.
盐酸美贝维林(MbHCl)的凝胶制剂含有羟丙基甲基纤维素(HPMC)、甲基纤维素(MTL)和泊洛沙姆 407(PLX),旨在用于治疗不同的口腔疼痛状况。HPMC 用作粘膜粘附凝胶基质,而 MTL 和 PLX 用于制备溶胶-凝胶热敏凝胶。MTL 和 PLX 制剂表现出适当的溶胶-凝胶相变温度,适合口腔内应用。制剂的评价指标包括粘度、机械性能、粘膜粘附性、稳定性和体外药物释放。含有 2%的 HPMC K100M 的制剂在室温下提供最高的粘度。然而,HPMC-PLX 混合物的粘度在体温下显著增加。HPMC-PLX 组合也表现出最大的粘膜粘附性。质地分析显示了制剂的粘附、硬度、弹性、内聚性和可压缩性的差异。获得了 MbHCl 的释放曲线,并且所有制剂都观察到非菲克扩散释放。制剂在不同的温度和相对湿度下储存。在 3 个月结束时,没有观察到明显的变化。选择盐酸美贝维林的 HPMC-PLX 制剂进行体内研究,它在兔子口腔粘膜组织上的停留时间比染料溶液更长。它被发现值得进一步的临床评估。